Xiwen Xiong Selected Research

Xiwen Xiong Research Topics

Disease

8	Inflammation (Inflammations) 12/2022 - 01/2017
5	Insulin Resistance 10/2021 - 01/2013
3	Hyperplasia 12/2022 - 11/2020
3	Fatty Liver 11/2021 - 07/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 10/2013
2	Colitis 01/2021 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 11/2016 - 01/2013
1	Hypertension (High Blood Pressure) 01/2023
1	Infections 12/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Neoplasms (Cancer) 11/2021
1	Fibrosis (Cirrhosis) 11/2021
1	Carcinogenesis 11/2021
1	Ulcerative Colitis 01/2021
1	Weight Gain 11/2020
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Dysbiosis 01/2018
1	Genomic Instability 01/2017
1	Hypersensitivity (Allergy) 01/2016
1	Alcoholic Fatty Liver 05/2013
1	Hyperglycemia 01/2013
1	Starvation 11/2012
1	Hypophosphatemic Rickets 01/2008

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2022 - 11/2012
3	Mechanistic Target of Rapamycin Complex 1IBA 11/2021 - 01/2021
3	Sirolimus (Rapamycin)FDA Link 11/2021 - 05/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2013
2	CytokinesIBA 12/2022 - 01/2021
2	AlarminsIBA 12/2022 - 07/2022
2	NAD (NADH)IBA 12/2021 - 11/2019
2	Nicotinamide MononucleotideIBA 12/2021 - 01/2018
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 07/2014
2	SirtuinsIBA 11/2019 - 01/2017
2	Insulin (Novolin)FDA Link 01/2013 - 01/2013
1	Captopril (Capoten)FDA LinkGeneric 01/2023
1	Tamoxifen FDA LinkGeneric 01/2023
1	NitritesIBA 01/2023
1	NitratesIBA 01/2023
1	Interleukin-33IBA 12/2022
1	Interleukin-17 (Interleukin 17)IBA 12/2022
1	AcetylglucosamineIBA 12/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 11/2021
1	CarcinogensIBA 11/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	torinIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Fenofibrate (CiL)FDA LinkGeneric 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2020
1	LipidsIBA 11/2019
1	EnzymesIBA 01/2018
1	hexosaminidase CIBA 01/2018
1	nicotinamide-beta-ribosideIBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 11/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Deoxyribonuclease I (Nickase)IBA 01/2016
1	Mechanistic Target of Rapamycin Complex 2IBA 04/2015
1	LDL CholesterolIBA 10/2013
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2013
1	Pyruvic Acid (Pyruvate)IBA 01/2013
1	Oxidoreductases (Dehydrogenase)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	Phosphates (Orthophosphate)IBA 01/2008

Therapy/Procedure

1	Intraperitoneal Injections 12/2021
1	Glycemic Control 11/2020
1	Fecal Microbiota Transplantation 01/2018